Rezolute (RZLT) Capital Leases (2014 - 2015)

Rezolute's (RZLT) quarterly Capital Leases came in at $23127.0 in Q2 2015, down 50.74% quarter-over-quarter from $46946.0 in Q1 2015.

Rezolute (RZLT) Capital Leases (2014 - 2015) Analysis & Trends

Rezolute has disclosed Capital Leases across 2 years of filings, most recently posting $23127.0 for Q2 2015.

Capital Leases for Q2 2015 came in at $23127.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2015 was $23127.0 (changed N/A YoY), and the FY2015 annual result was $23127.0, changed N/A from the prior year.
Capital Leases came in at $23127.0 for Q2 2015 at Rezolute, down from $46946.0 in the prior quarter.
In the past five years, Capital Leases ranged from a high of $70677.0 in Q4 2014 to a low of $8075.0 in Q3 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Rezolute	520.13 Mn	520.13 Mn	-

Download Data